Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.07T
Market cap1.07T
Price-Earnings ratio
37.91
Price-Earnings ratio37.91
Dividend yield
0.60%
Dividend yield0.60%
Average volume
2.35M
Average volume2.35M
High today
$1,153.45
High today$1,153.45
Low today
$1,123.78
Low today$1,123.78
Open price
$1,142.20
Open price$1,142.20
Volume
2.11M
Volume2.11M
52 Week high
$1,292.65
52 Week high$1,292.65
52 Week low
$712.05
52 Week low$712.05

Stock Snapshot

Eli Lilly(LLY) stock is priced at $1,137.46, giving the company a market capitalization of 1.07T. It carries a P/E multiple of 37.91 and pays a dividend yield of 0.60%.

On 2026-09-14, Eli Lilly(LLY) stock traded between a low of $1,123.78 and a high of $1,153.45. Shares are currently priced at $1,137.46, which is +1.2% above the low and -1.4% below the high.

The Eli Lilly(LLY)'s current trading volume is 2.11M, compared to an average daily volume of 2.35M.

During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.

During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.

LLY News

TipRanks 1h
Eli Lilly Stock Has 45% Upside, Says Citigroup - TipRanks

...

Eli Lilly Stock Has 45% Upside, Says Citigroup - TipRanks
TipRanks 4h
Lilly Refines Abemaciclib Delivery in New Phase 1 Study, Supporting Long-Term Oncology Strategy

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The study, officially titled “A Phase 1, Open-Label, Randomized, Crossover Stu...

MarketWatch 7h
Novo drops ‘Nordisk’ in corporate refresh to take on Lilly in the weight-loss wars

Novo Nordisk, the Danish drug giant behind Ozempic, is streamlining its corporate culture and shortening its name as it tries to better compete in the market fo...

Novo drops ‘Nordisk’ in corporate refresh to take on Lilly in the weight-loss wars

Analyst ratings

81%

of 32 ratings
Buy
81.3%
Hold
12.5%
Sell
6.3%

More LLY News

Nasdaq 12h
Novartis Just Shook Up a Multibillion-Dollar Drug Race. What It Means for Eli Lilly Stock.

Key Points Novartis recently announced bad news for its Lp(a)-lowering drug, pelacarsen. Lilly is also developing a therapy for lowering Lp(a). However, Nova...

Novartis Just Shook Up a Multibillion-Dollar Drug Race. What It Means for Eli Lilly Stock.
Nasdaq 23h
Novo Nordisk May Be Poised to Outpace Eli Lilly With This Key Catalyst

Key Points Novo Nordisk launched its Wegovy pill in early 2026, with Eli Lilly quickly following with a pill called Foundayo. Novo Nordisk's pill has been ver...

Novo Nordisk May Be Poised to Outpace Eli Lilly With This Key Catalyst
TipRanks 3d
Lilly’s Tirzepatide Targets Kidney Risk: What This Completed Trial Means for LLY Investors

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The study, officially titled “Tirzepatide Study of Renal Function in People Wi...

Benzinga 3d
Eli Lilly Utilizes Weight-Loss Drug Profits To Fund Women's Health Initiatives: Report

Eli Lilly & Co. (NYSE:LLY) is reportedly preparing to expand into the women’s health sector. The pharmaceutical giant is gathering specialists and researching...

Eli Lilly Utilizes Weight-Loss Drug Profits To Fund Women's Health Initiatives: Report
TipRanks 3d
Eli Lilly Stock in Focus as Company Completes AtaiBeckley Purchase

U.S. pharmaceutical giant Eli Lilly (LLY) has announced that it completed its acquisition of AtaiBeckley (ATAI), a biopharmaceutical company developing treatmen...

TipRanks 3d
Eli Lilly completes acquisition of AtaiBeckley

Eli Lilly and Company (LLY) announced the successful completion of its acquisition of AtaiBeckley (ATAI). AtaiBeckley is a clinical-stage biopharmaceutical comp...

TipRanks 3d
Novo Nordisk Stock Falls After Morgan Stanley’s Sell Call on Market Share Loss to Eli Lilly, Patent Cliff

Novo Nordisk shares (NVO) fell by 2% to about $43 early Friday after Morgan Stanley analyst Thibault Boutherin downgraded the Danish pharma giant from Hold to S...

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.